Zhongzhu Healthcare Holding Co (SHSE:600568) Cyclically Adjusted Revenue per Share: ¥0.39 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600568 Zhongzhu Healthcare Holding Co Ltd SHSE:600568
57 GF Score
Price ¥2.22
GF Value ¥1.89
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Zhongzhu Healthcare Holding Co Cyclically Adjusted Revenue per Share?

Zhongzhu Healthcare Holding Co SHSE:600568 57 Cyclically Adjusted Revenue per Share is ¥0.39 as of Mar. 2026. GuruFocus rates SHSE:600568 with a GF Score™ of 57/100 and a GF Value™ of ¥1.89 (Modestly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Zhongzhu Healthcare Holding Co's adjusted revenue per share for the three months ended in Mar. 2026 was ¥0.057. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥0.39 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Zhongzhu Healthcare Holding Co's average Cyclically Adjusted Revenue Growth Rate was -9.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -12.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -10.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -12.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Zhongzhu Healthcare Holding Co was 5.60% per year. The lowest was -22.10% per year. And the median was -8.10% per year.

As of today (2026-08-11), Zhongzhu Healthcare Holding Co's current stock price is ¥2.22. Zhongzhu Healthcare Holding Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ¥0.39. Zhongzhu Healthcare Holding Co's Cyclically Adjusted PS Ratio of today is 5.69.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Zhongzhu Healthcare Holding Co was 7.85. The lowest was 1.59. And the median was 3.07.


Zhongzhu Healthcare Holding Co  (SHSE:600568) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Zhongzhu Healthcare Holding Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2.22/0.39
=5.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Zhongzhu Healthcare Holding Co was 7.85. The lowest was 1.59. And the median was 3.07.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Zhongzhu Healthcare Holding Co Cyclically Adjusted Revenue per Share Related Terms


Zhongzhu Healthcare Holding Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Zhongzhu Healthcare Holding Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhongzhu Healthcare Holding Co Cyclically Adjusted Revenue per Share Chart

Zhongzhu Healthcare Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 0.59 0.53 0.44 0.39

Zhongzhu Healthcare Holding Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.43 0.42 0.39 0.39

SHSE:600568 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Zhongzhu Healthcare Holding Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhongzhu Healthcare Holding Co Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhongzhu Healthcare Holding Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Zhongzhu Healthcare Holding Co's Cyclically Adjusted PS Ratio falls into.


SHSE:600568
57GF Score
Zhongzhu Healthcare Holding Co Ltd SHSE:600568
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhongzhu Healthcare Holding Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhongzhu Healthcare Holding Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.057/116.3033*116.3033
=0.057

Current CPI (Mar. 2026) = 116.3033.

Zhongzhu Healthcare Holding Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.359 101.400 0.412
201609 0.225 102.400 0.256
201612 0.092 102.600 0.104
201703 0.117 103.200 0.132
201706 0.065 103.100 0.073
201709 0.128 104.100 0.143
201712 0.181 104.500 0.201
201803 0.126 105.300 0.139
201806 0.094 104.900 0.104
201809 0.039 106.600 0.043
201812 0.028 106.500 0.031
201903 0.053 107.700 0.057
201906 0.063 107.700 0.068
201909 0.074 109.800 0.078
201912 0.158 111.200 0.165
202003 0.066 112.300 0.068
202006 0.094 110.400 0.099
202009 0.065 111.700 0.068
202012 0.111 111.500 0.116
202103 0.047 112.662 0.049
202106 0.068 111.769 0.071
202109 0.086 112.215 0.089
202112 0.106 113.108 0.109
202203 0.063 114.335 0.064
202206 0.064 114.558 0.065
202209 0.064 115.339 0.065
202212 0.063 115.116 0.064
202303 0.059 115.116 0.060
202306 0.068 114.558 0.069
202309 0.064 115.339 0.065
202312 0.122 114.781 0.124
202403 0.065 115.227 0.066
202406 0.062 114.781 0.063
202409 0.069 115.785 0.069
202412 0.065 114.893 0.066
202503 0.071 115.116 0.072
202506 0.082 114.907 0.083
202509 0.065 115.471 0.065
202512 0.087 115.832 0.087
202603 0.057 116.303 0.057

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ¥0.39 mean?
Zhongzhu Healthcare Holding Co (SHSE:600568) has a Cyclically Adjusted Revenue per Share of ¥0.39 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Zhongzhu Healthcare Holding Co and its competitors.
Is Zhongzhu Healthcare Holding Co's Cyclically Adjusted Revenue per Share too high?
Zhongzhu Healthcare Holding Co's current Cyclically Adjusted Revenue per Share is ¥0.39. Overall, Zhongzhu Healthcare Holding Co has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhongzhu Healthcare Holding Co's Cyclically Adjusted Revenue per Share compare to ZTS?
Zhongzhu Healthcare Holding Co's Cyclically Adjusted Revenue per Share of ¥0.39 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Zhongzhu Healthcare Holding Co and its competitors. Zhongzhu Healthcare Holding Co's current Cyclically Adjusted Revenue per Share is ¥0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongzhu Healthcare Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Zhongzhu Healthcare Holding Co (SHSE:600568) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥1.89, compared to a current price of ¥2.22 — trading 17.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is ¥0.39. Zhongzhu Healthcare Holding Co's overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Zhongzhu Healthcare Holding Co (SHSE:600568), the current Cyclically Adjusted Revenue per Share is ¥0.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhongzhu Healthcare Holding Co (SHSE:600568) Overvalued in 2026?

Based on GuruFocus' analysis, Zhongzhu Healthcare Holding Co stock appears to be overvalued. The current stock price of ¥2.22 is trading 17.5% above its estimated GF Value™ of ¥1.89. GuruFocus considers Zhongzhu Healthcare Holding Co to be Modestly Overvalued.

Key valuation signals for SHSE:600568:

  • Cyclically Adjusted Revenue per Share: ¥0.39
  • GF Value™: ¥1.89 vs. price of ¥2.22 (17.5% above fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600568 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhongzhu Healthcare Holding Co Business Description

Address No. 1 Qinglu South Road, 8th Floor, Building 5, Yanlord Marina Center, Zhuhai, CHN, 519020
Zhongzhu Healthcare Holding Co Ltd produces and sells ophthalmic, antiviral, and anti-infective drugs in China. Its products include eye and nasal drops, injections, solid preparations, and other products. The product consists of Pearl Eye Drops, Sodium Cromolyn Eye Drops, Acyclovir Eye Drops, Hydroxybenzazole Hydrochloride Eye Drops, Acyclovir Dispersible Tablets, Gatifloxacin Tablets.
57GF Score

Get the complete analysis for SHSE:600568

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥2.22
Price
¥1.89
GF Value